Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7382 p4
7 January 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary

Related websites
Drug donations guidance


Drug donations cause health and economic problems

Inappropriate donations

Inappropriate donations hinder the work of health staff

In an emergency situation, drug donations are useless — they cause additional public health problems for the affected population and economic problems for the country, a report by the humanitarian organisation Pharmaciens Sans Frontières (PSF) concludes.

Shortly after the tsunami in South-East Asia, PSF reported that tonnes of inappropriate medicines were arriving in the region (PJ, 5 February 2005, p139). Between 20 May and 20 July 2005, it carried out a survey, funded by the World Health Organization, to assess the usefulness of drug donations for the population living in the tsunami-affected districts of Aceh Province, Indonesia. The survey targeted health centres, hospitals, pharmaceutical warehouses, ports and airports, and national and international non-governmental organisations.

Although no drug requests had been made, the survey revealed that 4,000 tonnes of drugs were received for a population of two million. Drugs were donated from 53 Indonesian organisations, 48 international organisations and 39 foreign governments. Of the drugs donated, 60 per cent were not on the national list of essential drugs, 70 per cent were labelled in a foreign language, and 25 per cent had an inadequate expiry date.

Excessive quantities of appropriate drugs, such as oral rehydration salts, dextromethorphan and tetracycline, also arrived and, based on the current rate of consumption, will not be used before their expiry dates.

Storage capacity in the province was greatly reduced by the tsunami and nearly half of health personnel died. The survey found that this has led to drugs being stored in offices, corridors, patients’ rooms and outside in courtyards and sheds. “Such conditions of storage cannot guarantee the quality of drugs. In addition, overcrowding greatly hinders the work and movements of health staff and patients in hospitals and health centres,” says a report of the survey results.

Waste disposal is a further issue. The survey revealed that about 600 tonnes of donations need to be destroyed due to inadequate expiry dates. The PSF estimate that the cost of disposal will be about €2.4m.

The PSF acknowledges that many organisations are trained and prepared for immediate action after a disaster, but says that in the post-emergency phase technical support should be provided by pharmaceutical experts to the health authorities of the recipient countries. “The objective is to assess what the actual needs for drugs are, as well as drug storage needs, drug distribution needs, and training needs for local health professionals,” it says. The PSF recommends that good drug donation practices should be mandatory for all donor organisations. The “Guidelines for drug donations”, published 10 years ago by the WHO, should be included in the national drug policy of countries and should be internationally regulated as a public health protection measure, says the report.

Back to Top


©The Pharmaceutical Journal